Nathan D G
Dana-Farber Cancer Institute, Boston, Mass 02115, USA.
JAMA. 1998 Oct 28;280(16):1427-31. doi: 10.1001/jama.280.16.1427.
The proportion of investigators applying for clinical research grants from the National Institutes of Health (NIH) who are physicians has declined from 40% 30 years ago to 25% today.
To recommend NIH policy changes that might encourage physician investigators to undertake careers in clinical research, eg, patient-oriented research, epidemiologic and behavioral studies, outcomes research, and health services research.
The NIH Director's Panel on Clinical Research comprised 14 physicians from academia and industry, chosen by the director. They met in numerous closed sessions and in 5 public meetings from July 1995 to November 1997.
In addition to expert opinion and pertinent literature, data sources included the training characteristics of applicants to NIH who were funded or not. Topics considered included financing of clinical research, recruitment, training, and retention of future clinical investigators, conduct of clinical trials, and peer review of clinical research. Consensus was reached and recommendations were made in response to an interim report, widely circulated to the biomedical community, written by members of the panel, which contained preliminary recommendations.
The panel's final recommendations to NIH included maintaining at least the present proportion of NIH funding for clinical research; continuing mentored opportunities in clinical research for medical students; promoting clinical research training by offering didactic courses and grant opportunities in clinical research to nascent investigators emerging from specialty training programs and providing partial salary support for mentors; restructuring study sections that review patient-oriented research applications to include more physicians; encouraging clinical investigators and basic scientists to work closely together and weld collaborations between academic clinical investigators and colleagues in pharmaceutical and biotechnology companies; and developing a joint policy between academic health centers and NIH for the support of clinical research and clinical research training.
申请美国国立卫生研究院(NIH)临床研究资助的研究人员中,医生所占比例已从30年前的40%降至如今的25%。
推荐NIH的政策变革,以鼓励医生研究人员投身临床研究事业,如开展以患者为导向的研究、流行病学和行为学研究、结果研究以及卫生服务研究。
NIH临床研究主任小组由主任挑选的14位来自学术界和业界的医生组成。他们于1995年7月至1997年11月期间召开了多次闭门会议和5次公开会议。
除专家意见和相关文献外,数据来源还包括获得或未获得NIH资助的申请者的培训特点。所考虑的主题包括临床研究的资金筹措、未来临床研究人员的招募、培训和留用、临床试验的开展以及临床研究的同行评审。针对小组成员撰写并广泛分发给生物医学界的一份中期报告(其中包含初步建议),达成了共识并提出了建议。
该小组向NIH提出的最终建议包括:至少维持目前临床研究在NIH资助中所占的比例;继续为医学生提供临床研究的指导机会;通过为刚从专科培训项目结业的新研究人员提供临床研究的教学课程和资助机会,并为导师提供部分薪资支持,来促进临床研究培训;重组负责评审以患者为导向的研究申请的研究小组,使其纳入更多医生;鼓励临床研究人员和基础科学家密切合作,并促成学术临床研究人员与制药和生物技术公司的同事之间的合作;制定学术健康中心与NIH之间的联合政策,以支持临床研究和临床研究培训。